ID: ALA4436300

Max Phase: Preclinical

Molecular Formula: C40H68N12O11

Molecular Weight: 893.06

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CC(=O)NCCCCN1C(=O)[C@H]2CCCN2C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H]1C

Standard InChI:  InChI=1S/C40H68N12O11/c1-22(2)17-27-36(60)49-26(11-9-14-44-40(41)42)35(59)46-21-32(55)48-28(19-33(56)57)37(61)50-29(18-23(3)4)38(62)52-16-10-12-30(52)39(63)51(15-8-7-13-43-25(6)53)24(5)34(58)45-20-31(54)47-27/h22-24,26-30H,7-21H2,1-6H3,(H,43,53)(H,45,58)(H,46,59)(H,47,54)(H,48,55)(H,49,60)(H,50,61)(H,56,57)(H4,41,42,44)/t24-,26-,27-,28-,29-,30+/m0/s1

Standard InChI Key:  WYADQJPQUJCCTC-UJJOWMEUSA-N

Associated Targets(Human)

Integrin alpha-V/beta-8 181 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Integrin alpha-V/beta-6 509 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 893.06Molecular Weight (Monoisotopic): 892.5131AlogP: -2.87#Rotatable Bonds: 15
Polar Surface Area: 343.52Molecular Species: ZWITTERIONHBA: 11HBD: 11
#RO5 Violations: 3HBA (Lipinski): 23HBD (Lipinski): 12#RO5 Violations (Lipinski): 3
CX Acidic pKa: 4.04CX Basic pKa: 11.44CX LogP: -6.02CX LogD: -6.02
Aromatic Rings: 0Heavy Atoms: 63QED Weighted: 0.04Np Likeness Score: 0.53

References

1. Reichart F, Maltsev OV, Kapp TG, Räder AFB, Weinmüller M, Marelli UK, Notni J, Wurzer A, Beck R, Wester HJ, Steiger K, Di Maro S, Di Leva FS, Marinelli L, Nieberler M, Reuning U, Schwaiger M, Kessler H..  (2019)  Selective Targeting of Integrin αvβ8 by a Highly Active Cyclic Peptide.,  62  (4): [PMID:30657681] [10.1021/acs.jmedchem.8b01588]

Source